Literature DB >> 24792695

High-performance liquid chromatography coupled with post-column dual-bioactivity assay for simultaneous screening of xanthine oxidase inhibitors and free radical scavengers from complex mixture.

D Q Li1, J Zhao2, S P Li3.   

Abstract

Xanthine oxidase (XO) can catalyze hypoxanthine and xanthine to generate uric acid and reactive oxygen species (ROS), including superoxide anion radical (O₂(•-)) and hydrogen peroxide. XO inhibitors and free radical scavengers are beneficial to the treatment of gout and many related diseases. In the present study, an on-line high-performance liquid chromatography (HPLC) coupled with post-column dual-bioactivity assay was established and successfully applied to simultaneously screening of XO inhibitors and free radical scavengers from a complex mixture, Oroxylum indicum extract. The integrated system of HPLC separation, bioactivity screening and mass spectrometry identification was proved to be simple and effective for rapid and sensitive screening of individual bioactive compounds in complex mixtures.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Free radical scavengers; Post-column dual-bioactivity assay; Xanthine oxidase inhibitors

Mesh:

Substances:

Year:  2014        PMID: 24792695     DOI: 10.1016/j.chroma.2014.03.065

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Time-course and intensity-based classifications of oxidative stresses and their potential application in biomedical, comparative and environmental research.

Authors:  Volodymyr I Lushchak
Journal:  Redox Rep       Date:  2016-02-05       Impact factor: 4.412

2.  Optimization of Supercritical Fluid Extraction of Total Alkaloids, Peimisine, Peimine and Peiminine from the Bulb of Fritillaria thunbergii Miq, and Evaluation of Antioxidant Activities of the Extracts.

Authors:  Xiao Ruan; Li Yang; Wen-Xia Cui; Men-Xing Zhang; Zhao-Hui Li; Ben Liu; Qiang Wang
Journal:  Materials (Basel)       Date:  2016-06-29       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.